Eli Lilly kicks off 2025 with key licensing deals and M&A, boosting its position across therapeutic areas amid rising drug ...
Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
Find out about what's behind the increase of securities class action lawsuits in the biotech industry and how to prevent them ...
When David Bennet received a new heart in January 2022, there was something very unusual about the organ being transplanted into his body – instead of coming from a human donor, it was actually a ...
Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news of 2025. We meticulously curate and categorize the latest collaborations and M&A activities, ensuring you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results